LymphomaPatient StoriesPediatric Cancer
To disclose or not to disclose having cancer, that is the question. Tonya Marie Pan, a survivor of stage III non-Hodgkin lymphoblastic lymphoma, shares insights into the difficulties of communicating with others as a patient with cancer.
By Tracy Wright
Following 6 months of intensive chemotherapy to treat his stage IV non-Hodgkin lymphoma, Dan Dean decided he wasn’t comfortable having a bone marrow transplant.
FDA Approvals, News & UpdatesLymphomaNewsworthy
In October 2017, the FDA accelerated the approval of Calquence for the treatment of adults with mantle-cell lymphoma who have received at least 1 previous therapy.
By Kelsey Moroz
“The first thing I said was, there’s no way. I consider myself the healthiest person I know. There’s nothing that I did that could have caused cancer,” Rachelle said. “I was just in complete shock.”
Celebrating Progress and Sharing Hope: The Leukemia & Lymphoma Society to Host Free Rocky Mountain Blood Cancer Conference for Blood Cancer Patients, Survivors and Caregivers
The Leukemia & Lymphoma Society (LLS) will be hosting its 8th Annual Rocky Mountain Blood Cancer Conference on Saturday, April 7, 2018, at the Hyatt Regency Aurora-Denver Conference Center. LLS Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals.
By Carlo Lopez
NHL survivor Carlo Lopez shares his personal experience with cancer and his goal of becoming an oncology nurse to offer other people the knowledge and experience he gained as a patient.
“CAR T-cell therapy provides an exciting and additional option for patients who have failed more traditional regimens,” says Dr. Gwen Nichols, Chief Medical Officer for Leukemia & Lymphoma Society.
After being hit by “the cancer bomb” at age 20 and inspired by her grandfather’s experience with cancer, Madison Miller started a nonprofit organization to provide resources for other patients with cancer.
Common signs and symptoms of mantle-cell lymphoma may be similar to other conditions. A comprehensive workup including a physical examination, lab tests, and imaging may be required to establish a definitive diagnosis and identify the disease stage.
Electronic medical records can help healthcare providers communicate and share information more efficiently than ever before, resulting in tangible benefits for patients with cancer.
If their first treatment stops working, patients with mantle-cell lymphoma are prescribed a different therapy. Several new treatment options are available for these patients, with several more being studied in clinical trials.
Many clinical trials are taking place to investigate new drugs for treating mantle-cell lymphoma. Patients who are thinking about participating in a clinical trial should speak with their healthcare team to get all the facts before making their decision.
In February 2019, the FDA issued a letter to raise awareness of the risk for a rare type of lymphoma, BIA-ALCL, that is linked to all types of breast implants. Although this is an uncommon reaction to implants, all women who have or intend to get an implant after breast cancer should be aware of this risk. Learn more about this risk here.
Page 1 of 2
Results 1 - 34 of 36
Results 1 - 34 of 36